UroToday - Bladder Cancer

Home

Bladder Cancer

UroToday's Bladder Cancer section is a repository of the clinical publications, clinical trials and investigative science pertaining to the diagnosis and treatment of bladder cancer. Also available are conference coverage for all timely bladder cancer science, audio podcasts and downloadable slides from UroToday's slide library.

Online Urology & Urologic Oncology Journal
Please read about the UroToday International Journal; We welcome submissions year round and are committed to providing fast-tracked, peer reviewed publication.

Display

results per page

Results 151 - 200 of 1983

<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Bladder preservation in octogenarians with invasive bladder cancer - Abstract
Wednesday, 06 January 2010
Department of Urology and Andrology, Donauspital Langobardenstrasse, Vienna, Austria
read more

The presence of circulating tumor cells does not predict extravesical disease in bladder cancer patients prior to radical cystectomy - Abstract
Tuesday, 05 January 2010
The James Buchanan Brady Urological Institute, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA.
read more

How do commonly performed lymphadenectomy templates influence bladder cancer nodal stage? - Abstract
Tuesday, 05 January 2010
Department of Urology, Comprehensive Cancer Center, Ohio State University, Columbus, Ohio.
read more

Expression of HYAL1 and survivin RNA as diagnostic molecular markers for bladder cancer - Abstract
Tuesday, 05 January 2010
Oncology Diagnostic Unit, Medical Biochemistry Department, Ain Shams University, Cairo, Egypt.
read more

Molecular characterization of upper urinary tract tumours - Abstract
Tuesday, 05 January 2010
Department of Urology and Laboratory of Urology, Hospital Clinic, Barcelona, Spain.
read more

Should bladder cuff excision remain the standard of care at nephroureterectomy in patients with urothelial carcinoma of the renal pelvis? A population-based study - Abstract
Tuesday, 05 January 2010
Cancer Prognosis and Health Outcomes Unit, University of Montreal Health Center, Montreal, Québec, Canada;
read more

Photocure received positive response from FDA on the new drug application (NDA) for Hexvix for detection of bladder cancer
Monday, 04 January 2010
OSLO, NORWAY (Press Release) - December 31, 2009
read more

Risk of urinary bladder cancer: a case-control analysis of industry and occupation - Abstract
Monday, 04 January 2010
Uncertainty remains about urinary bladder cancer (UBC) risk for many occupations.
read more

Intravesical therapy use in the high risk patient: practice patterns in an equal access healthcare institution before and after national guidelines - Abstract
Monday, 04 January 2010
Department of Surgery, Urology Service, Madigan Army Medical Center, Tacoma, Washington, USA.
read more

Photodynamic diagnosis in non-muscle-invasive bladder cancer: A systematic review and cumulative analysis of prospective studies - Abstract
Monday, 04 January 2010
Department of Urology, University at Lübeck, University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany.
read more

Predicting individual outcomes after radical cystectomy: an external validation of current nomograms - Abstract
Friday, 01 January 2010
Departments of Urology, Ludwig-Maximilians-Universität München, Munich.
read more

Narrow-band imaging cystoscopy to evaluate bladder tumours - individual surgeon variability - Abstract
Friday, 01 January 2010
Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
read more

Management of urethral recurrence after orthotopic urinary diversion - Abstract
Friday, 01 January 2010
Departments of Urology and Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
read more

The effect of gender on response to bacillus Calmette-Guérin therapy for patients with non-muscle-invasive urothelial carcinoma of the bladder - Abstract
Thursday, 31 December 2009
Biostatistics, Fox Chase Cancer Center, Philadelphia, PA.
read more

Lymph node mapping in patients with bladder cancer undergoing radical cystectomy and lymph node dissection to the level of the inferior mesenteric artery - Abstract
Thursday, 31 December 2009
Department of Urology, Aarhus University Hospital, Skejby, and Institute of Pathology, Aarhus University Hospital, Aarhus Sygehus NBG, Denmark.
read more

Pathological stage review is indicated in primary pT1 bladder cancer - Abstract
Thursday, 31 December 2009
Department of Surgical Oncology, Division of Urology, Toronto, Canada.
read more

Urinary diversion after cystectomy for bladder cancer: A population-based study in Sweden - Abstract
Monday, 28 December 2009
Department of Urology, University Hospital, Linköping, Sweden.
read more

Cost analysis of robotic versus open radical cystectomy for bladder cancer - Abstract
Monday, 28 December 2009
Division of Urologic Surgery, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
read more

Emerging targeted therapies for bladder cancer: a disease waiting for a drug - Abstract
Friday, 25 December 2009
Cancer and Infection Research Area, AstraZeneca, Mereside, Alderley Park, Macclesfield, Cheshire, SK10 4TG, UK.
read more

The role of bacillus Calmette-Guérin in the treatment of non-muscle-invasive bladder cancer - Abstract
Thursday, 24 December 2009
Department of Urology, University of Turin, Molinette Hospital, Turin, Italy.
read more

Tumor multiplicity is an independent prognostic factor of non-muscle-invasive high-grade (T1G3) bladder cancer - Abstract
Thursday, 24 December 2009
Department of Urology, Osaka University Graduate School of Medicine, Osaka, Japan.
read more

Strategies for molecular expression profiling in bladder cancer - Abstract
Thursday, 24 December 2009
Department of Pathology, University of Southern California Keck School of Medicine, 2011 Zonal Avenue, HMR 308, Los Angeles, CA, 90033, USA.
read more

Bladder cancer detection, treatment and outcomes: Opportunities and challenges - Abstract
Wednesday, 23 December 2009
Scott Department of Urology and Dan L Duncan Cancer Center, Baylor College of Medicine, Houston, Texas.
read more

Local and global panoramic imaging for fluorescence bladder endoscopy - Abstract
Wednesday, 23 December 2009
Institute of Imaging & Computer Vision, RWTH Aachen University, 52056 Aachen, Germany.
read more

The role of actinin-4 in bladder cancer invasion - Abstract
Wednesday, 23 December 2009
Department of Urology, Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima, Japan.
read more

Testing for urinary hyaluronate improves detection and grading of transitional cell carcinoma - Abstract
Tuesday, 22 December 2009
Department of Urology, Laboratory of Medical Investigation (LIM55), Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, Brazil.
read more

Cell-penetrating d-isomer peptides of p53 C-terminus: Long-term inhibitory effect on the growth of bladder cancer - Abstract
Tuesday, 22 December 2009
Department of Physiology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
read more

Fluid intake and the risk of bladder cancer: Results from the South and East China case-control study on bladder cancer - Abstract
Friday, 18 December 2009
Unit of Genetic Epidemiology. Department of Public Health, Epidemiology & Biostatistics. University of Birmingham, Birmingham, UK.
read more

Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract - Abstract
Friday, 18 December 2009
Medical University of Graz, Graz, Austria.
read more

Postoperative nomogram for invasive bladder cancer: Does it really work? A multicenter cohort study - Abstract
Friday, 18 December 2009
Università Cattolica S. Cuore, Policlinico A. Gemelli, Cattedra di Urologia, Rome, Italy.
read more

Menthol induces cell death via the TRPM8 channel in the human bladder cancer cell line T24 - Abstract
Thursday, 17 December 2009
Graduate School, Southern Medical University, Guangzhou, China.
read more

Reactive antibodies against bacillus Calmette-Guerin heat-shock protein-65 potentially predict the outcome of immunotherapy for high-grade transitional cell carcinoma of the bladder - Abstract
Thursday, 17 December 2009
Department of Urology and Pediatric Urology, Bavarian Julius Maximilians-University Medical School, Wurzburg, Germany.
read more

Diagnostic random bladder biopsies: Reflections from a population-based cohort of 538 patients - Abstract
Thursday, 17 December 2009
Department of Molecular Medicine and Surgery, Section of Urology; Clinical Cancer Epidemiology, Department of Oncology-Pathology, Radiumhemmet, Karolinska University Hospital; Division of Urology, CLINTEC, Karolinska Institutet, Stockholm, Sweden; Clinical Cancer Epidemiology, Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden
read more

Role and rationale of gene therapy and other novel therapies in the management of NMIBC - Abstract
Wednesday, 16 December 2009
Department of Urology, King's College Hospital, London, UK.
read more

Comparing the safety and efficiency of conventional monopolar, plasmakinetic, and holmium laser transurethral resection of primary non-muscle invasive bladder cancer - Abstract
Wednesday, 16 December 2009
Department of Urology, First Affiliated Hospital of Dalian Medical University , Dalian, China.
read more

Inhibition of bladder cancer development by allyl isothiocyanate - Abstract
Wednesday, 16 December 2009
Department of Cancer Prevention and Control; Department of Urology; Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York 14263, USA.
read more

AUA NY 2009 - Controversies in the management of upper tract transitional cell carcinoma - Multimedia Presentation
Tuesday, 15 December 2009
SEWARD, AK, USA - Presented by Arthur D. Smith, MD at the 107th Annual Meeting of the AUA - New York Section - August 19 - 26, 2009, Seward, Alaska, USA
Login to read more...

Organ-sparing strategies in the management of invasive bladder cancer - Abstract
Tuesday, 15 December 2009
Department of Surgery (Urology), McGill University, Montreal, Quebec, Canada.
read more

Lymph node dissection for bladder cancer: the issue of extent and feasibility in the minimally invasive era - Abstract
Tuesday, 15 December 2009
Department of Urology, Montefiore Medical Center, Albert Einstein College of Medicine, 3400 Bainbridge Avenue, Bronx, NY 10467, USA.
read more

Increased frequency and nocturia in a middle aged male may not always be due to Benign Prostatic Hypertrophy (BPH): a case report - Abstract
Tuesday, 15 December 2009
Department of Medicine, University of Tennessee, College of Medicine, Chattanooga, TN, USA.
read more

Traffic air pollution and risk of death from bladder cancer in Taiwan using petrol station density as a pollutant indicator - Abstract
Monday, 14 December 2009
Institute of Occupational Safety and Health, College of Health Sciences, Kaohsiung Medical University, Kaohsiung, Taiwan.
read more

Management of patients with advanced bladder cancer following major response to systemic chemotherapy - Abstract
Monday, 14 December 2009
Department of Surgery (Urology), McGill University, Montreal, Quebec, Canada.
read more

SUO 2009 - Assessing the clinical benefit of NMP22 in the surveillance of patients with non-muscle-invasive bladder cancer: A decision-curve analysis - Slide Presentation
Friday, 11 December 2009
BETHESDA, MD, USA (UroToday.com) - Presented by Shahrokh Shariat, MD and Andrew Vickers, MD at the 10th Annual Winter Meeting of the Society of Urologic Oncology (SUO) - December 2 - 4, 2009 - National Institutes of Health, Bethesda, Maryland, USA
Login to read more...

SUO 2009 - Efficacy and safety of intravesical valrubicin in patients with carcinoma in situ of the bladder refractory to bacillis Calmette-Guérin: A phase III open-label, multicenter study - Session Highlights
Wednesday, 09 December 2009
BETHESDA, MD, USA (UroToday.com) - Gary Steinberg presented data on the efficacy of valrubicin (Val) for CIS patients with bladder cancer refractory to BCG.
Login to read more...

SUO 2009 - Recent advances in bladder cancer: Pros and cons of adjuvant versus neoadjuvant therapy - Session Highlights
Wednesday, 09 December 2009
BETHESDA, MD, USA (UroToday.com) - Dr. Dean Bajorin discussed peri-operative chemotherapy in bladder cancer.
Login to read more...

SUO 2009 - Assessing the clinical benefit of NMP22 in the surveillance of patients with non-muscle-invasive bladder cancer: A decision-curve analysis - Session Highlights
Wednesday, 09 December 2009
BETHESDA, MD, USA (UroToday.com) - Dr. Shahrokh Shariat presented data on NMP22.
Login to read more...

SUO 2009 - Recent advances in bladder cancer: Bladder cancer targeted therapeutics - Session Highlights
Wednesday, 09 December 2009
BETHESDA, MD, USA (UroToday.com) - Dr. Matthew Milwosky presented a talk on targeted therapies for bladder cancer.
Login to read more...

SUO 2009 - Panel discussion: Utility (or lack of) of FDA approved voided urine biomarkers - Session Highlights
Tuesday, 08 December 2009
BETHESDA, MD, USA (UroToday.com) - This session allowed the two persenters to provided opposing arguments about the utilization of voided urinary biomarkers.
Login to read more...

SUO 2009 - DNA methylation - Session Highlights
Tuesday, 08 December 2009
BETHESDA, MD, USA (UroToday.com) - DNA methylation identification was really started in 1996 with the introduction of methylation specific PCR.
Login to read more...

SUO 2009 - MSA trial - Session Highlights
Tuesday, 08 December 2009
BETHESDA, MD, USA (UroToday.com) - Dr. Mark Schoenberg presented clinical trial data on MSA for bladder cancer detection.
Login to read more...

Focus on Bladder Cancer

Focus on Bladder Cancer condenses a selection of compelling and relevant science - on topic and chosen by the UroToday.com editorial staff.

Exclusive!
Interview with Barry Stein, MD on Clinical Practice Experience with NMP22

Podcast - San Francisco Firefighters and Bladder Cancer Screening

Synergistic potentiation of interferon activity with maitake mushroom D-fraction on bladder cancer cells

- by Sensuke Konno, PhD, et al.

Non-invasive methods to detect schistosome-based bladder cancer: is the association sufficient for epidemiological use?

- by Clive Shiff, MD and Robert W. Veltri, MD

Urinary Bladder Cancer: Diffusion-Weighted MR Imaging--Accuracy for Diagnosing T Stage and Estimating Histologic Grade

- by Mitsuru Takeuchi, MD

Clinical Outcome of Chemoradiotherapy for T1G3 Bladder Cancer

- by Masaharu Inoue, MD, et al.

External Beam Radiation Therapy Followed by Interstitial Radiotherapy with Iridium-192 for Solitary Bladder Tumours: Results of 111 Treated Patients

- by lze E.W. van Onna, MD

Bladder Tumor Markers: From Hematuria to Molecular Diagnostics - Where Do We Stand?

- by Samir Shirodkar, MD

Familial and Genetic Risk of Transitional Cell Carcinoma of the Urinary Tract

- by Christine M. Mueller, DO, et al.

Bladder-Sparing Therapy for Muscle-Infiltrating Bladder Cancer

- by Paolo Emiliozzi, MD

Is the incidence of uretero-intestinal anastomotic stricture increased in patients undergoing radical cystectomy with previous pelvic radiation?

- by Christopher P. Evans, MD, FACS

The Novel Use of Intravesical Docetaxel for the Treatment of Non-Muscle Invasive Bladder Cancer Refractory to BCG Therapy: A Single Institution Experience

- by David P. Wood, Jr. MD

Predictive Value of Telomerase Reverse Transcriptase Expression in Patients with High Risk Superficial Bladder Cancer Treated with Adjuvant BCG Immunotherapy

- by David P. Wood, Jr. MD

Prognostic Significance of Nondiagnostic Molecular Changes in Urine Detected by UroVysion Fluorescence In Situ Hybridization During Surveillance for Bladder Cancer

- by David P. Wood, Jr. MD

Cultured Milk, Yogurt, and Dairy Intake in Relation to Bladder Cancer Risk in a Prospective Study of Swedish Women and Men

- by David P. Wood, Jr. MD

Adjuvant Methotrexate, Vinblastine, Adriamycin, and Cisplatin Chemotherapy has Potential to Prevent Recurrence of Bladder Tumors After Surgical Removal of Upper Urinary Tract Transitional Cell Carcinoma

- by David P. Wood, Jr. MD

Matrix Metalloproteinase Polymorphisms Are Associated with Bladder Cancer Invasiveness

- by Ricardo Sånchez-Ortiz, MD - Editor's Pick

Laparoscopic Radical Cystectomy for Cancer: Oncological Outcomes at up to 5 years

- by David P. Wood, Jr. MD - Editor's Pick

Safety and Efficacy of Ofloxacin on Bacillus Calmette-Guerin Induced Toxicity in Patients with Superficial Bladder Cancer

- by Yassine Nouira, MD, et al.

Efficacy of Bacillus Calmette-Guerin (BCG) Therapy and Cauterization of the Tumor Versus BCG Therapy Without Cauterization for Superficial Bladder Cancer

- by Siavash Falahatkar, MD, et al.

A Cost Comparison of the Diagnostic Modalities Used in the Detection of Urothelial Carcinoma in Patients Undergoing Evaluation for Hematuria

- by Louis S. Liou, MD, et al.

Utilization of the NMP22® BladderChek® Urine Test as an Adjunct to Atypical Cytology in the Detection of Bladder Cancer Recurrence

- by Ravi Munver, MD, et al.

Long Term Clinical Outcome of a Phase I Trial of Intravesical Docetaxel in the Management of Superficial Bladder Cancer Refractory to Standard Intravesical Therapy

- by Mitchell C. Benson, MD, and James M McKiernan, MD

Investigation of Publication Bias Using the Model of p53 Accumulation in Bladder Cancer

- by Peter J. Goebell, MD, et al.

Should All Patients Receive Single Chemotherapeutic Agent Instillation after Bladder Tumour Resection?

Therapeutic Options in the Management of Intermediate-Risk Nonmuscle-Invasive Bladder Cancer

Two Centuries of Cystoscopy: The Development of Imaging, Instrumentation and Synergistic Technologies

Bladder Cancer and the Aluminium Industry: A Review

Invasive T1 Bladder Cancer: Indications and Rationale for Radical Cystectomy

Bladder Cancer Screening

Improved Detection and Surveillance of Bladder Cancer Using a Point-of-Care NMP22 Assay

- by Mark S. Soloway, MD

Improving the Diagnosis of Bladder Cancer -Combining Cystoscopy with a Physician's Office Tumor Marker Test

- CME Training Program

Improved Detection of Bladder Cancer in Diagnosis and Surveillance Patients Using a Point-of-Care Proteomic Assay
- Barry Stein, MD on Improved Detection of Bladder Cancer in Diagnosis

Should We Screen for Bladder Cancer in a High Risk Population: A Cost per Life-Year Saved Analysis?
- Yair Lotan, MD on Screening for Bladder Cancer

Wisconsin Industrial Workers Might Be At Increased Risk For Bladder Cancer
- Giora Katz, MD Reports on Increased Risk for Bladder Cancer

Utility of NMP22 BladderCheck Point-Of-Care Assay In Evaluation Of Hematuria: A Multicenter Study
- Giora Katz, MD on the Utility of NMP22 Bladdercheck

Initial Diagnosis Of Bladder Cancer Using A Point-Of-Care Assay
- H. Barton Grossman, MD & the NMP22 Clinical Investigation Group

The impact of fibrin clot inhibitor medications on the efficacy of Bacillus Calmette-Guerin therapy for urothelial carcinoma of the bladder
- Session Highlight by Thomas J. Guzzo, MD, MPH from the AUA Mid-Atlantic Section 67th Annual Meeting

Management of non-muscle invasive bladder cancer: Use of 2007 AUA guidelines
- Multimedia Lecture by Muhammad Choudhury, MD from the AUA NY Section 107th Annual Meeting

Improving survival for patients with bladder cancer
- Multimedia Lecture by Ralph de Vere White, MD from the AUA NY Section 107th Annual Meeting

Fluorescence cystoscopy for detection of initial and recurrent bladder cancer
- Multimedia Lecture by Ihor Sawczuk, MD from the AUA NY Section 107th Annual Meeting

Early cystectomy for T1 bladder cancer
- Slide Presentation by David P. Wood, Jr., MD from the VI Maratona Urológica

Treatment of muscle invasive bladder cancer in elderly
- Slide Presentation by David P. Wood, Jr., MD from the VI Maratona Urológica

Robotic extended pelvic lymphadenectomy for bladder cancer: Initial experience with greater nodal yield
- Session Highlight by Jason Lee, MD, FRCSC from the 2009 World Congress of Endourology

Open versus robot-assisted radical cystectomy: Comparison of early outcomes and cost
- Session Highlight by Jason Lee, MD, FRCSC from the 2009 World Congress of Endourology

The impact of fibrin clot inhibitor medications on the efficacy of Bacillus Calmette-Guerin therapy for urothelial carcinoma of the bladder
- Presented by Stephen A. Boorjian, MD

American Society of Clinical Oncology (ASCO) 2009 Annual Meeting
- View Bladder Cancer Session Highlights
American Urological Association (AUA) 2009 Annual Meeting
- View Bladder Cancer Session Highlights from the AUA 2009 Annual Meeting
10 Tips for Non-Muscle Invasive Bladder Cancer
- Lecture presented at WUF 2009 by David P. Wood, Jr., MD

Society of Urologic Oncology (SUO) 9th Annual Winter Meeting
- View Bladder Cancer Session Highlights

Robot Assisted Radical Cystectomy: Is it Ready for Prime Time?
- Session Highlight from AUA Western Section 2008

Bladder Cancer Cytology and Markers in Diagnosis and Assessment
- Presentation from the 2008 AUA NY Meeting

Re-Staging Transurethral Resection: Who Benefits?
- Slide Presentation from the 2008 AUA NY Section Meeting

Non-Muscle Invasive Transitional Cell Carcinoma
- Slide Presentation from the 2008 Masters in Urology Conference
American Society of Clinical Oncology 44th Annual Meeting
- Bladder Cancer Abstracts

The American Urological Association 2008 Annual Meeting
- Bladder Cancer Session Highlights

Engineering and Urology Society 23rd Annual Meeting
- Bladder Cancer Abstracts